Poor in vivo characteristics of gambogic acid (GA) and difficulties in industrial manufacturing of its nanocarriers have hindered its clinical translation. Therefore, a reproducible nano‐drug delivery system must be developed to realize simpler manufacture and address inherent defects of GA, such as short circulation and severe side effects, in order to facilitate its clinical application. Herein, a drug self‐assembled nanoparticles (NPs) consisting of a hydrophobic prodrug based on GA and oleyl alcohol (OA), as well as vitamin E‐polyethylene glycol succinate (TPGS) as a shield to improve the stability of the NPs is reported. The preparation method is simple enough to stably facilitate large‐scale manufacturing. The self‐assembled NPs exhibit a remarkably high drug‐loading capacity, and their prolonged circulation enables the NPs to demonstrate superior antitumor efficacy in both cellular and animal models. The flexible hydrophobic long chain wraps GA groups, which mitigates vascular irritation and reduces hemolysis rates. Consequently, the prodrug nano‐system addresses GA‐related concerns regarding stability, efficacy, and safety, offering a simple, stable, and secure nano‐platform for similar candidate drugs.
甘草酸(GA)的体内特性差,其纳米载体的工业化生产困难重重,阻碍了其临床转化。因此,必须开发一种可重复的纳米给药系统,以实现更简单的制造,并解决甘草酸固有的缺陷,如循环时间短、副作用大等,从而促进其临床应用。本文报道了一种药物自组装纳米粒子(NPs),它由基于 GA 和油醇(OA)的疏水性原药以及维生素 E-聚乙二醇琥珀酸酯(TPGS)组成,后者作为保护层可提高 NPs 的稳定性。该制备方法非常简单,可稳定地促进大规模生产。自组装的 NPs 表现出极高的药物负载能力,其长时间的循环使 NPs 在细胞和动物模型中都表现出卓越的抗肿瘤功效。柔性疏水长链包裹着 GA 基团,从而减轻了对血管的刺激,降低了溶血率。因此,该原药纳米系统解决了与 GA 有关的稳定性、药效和安全性问题,为类似候选药物提供了一个简单、稳定和安全的纳米平台。
{"title":"Simplified Gambogic Acid Prodrug Nanoparticles to Improve Efficiency and Reduce Toxicity for Clinical Translation Potential","authors":"Ruyi Wang, Yuxiao Xiao, Zhongtao Zhang, Xiaoxian Huang, Wanfang Zhu, Xiao Ma, Feng Feng, Wenyuan Liu, Lingfei Han, Wei Qu","doi":"10.1002/adhm.202401950","DOIUrl":"https://doi.org/10.1002/adhm.202401950","url":null,"abstract":"Poor in vivo characteristics of gambogic acid (GA) and difficulties in industrial manufacturing of its nanocarriers have hindered its clinical translation. Therefore, a reproducible nano‐drug delivery system must be developed to realize simpler manufacture and address inherent defects of GA, such as short circulation and severe side effects, in order to facilitate its clinical application. Herein, a drug self‐assembled nanoparticles (NPs) consisting of a hydrophobic prodrug based on GA and oleyl alcohol (OA), as well as vitamin E‐polyethylene glycol succinate (TPGS) as a shield to improve the stability of the NPs is reported. The preparation method is simple enough to stably facilitate large‐scale manufacturing. The self‐assembled NPs exhibit a remarkably high drug‐loading capacity, and their prolonged circulation enables the NPs to demonstrate superior antitumor efficacy in both cellular and animal models. The flexible hydrophobic long chain wraps GA groups, which mitigates vascular irritation and reduces hemolysis rates. Consequently, the prodrug nano‐system addresses GA‐related concerns regarding stability, efficacy, and safety, offering a simple, stable, and secure nano‐platform for similar candidate drugs.","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":null,"pages":null},"PeriodicalIF":10.0,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142259678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinically, conventional sutures for repair of short‐distance nerve injuries (< 5 mm) may contribute to uncontrolled inflammation and scar formation, thus negatively impacting nerve regeneration. To repair transected peripheral nerves with short distances, a rapid‐forming, robust adhesive chitosan hydrogel is prepared by synthesizing maleic and dopamine bi‐functionalized fungal‐sourced chitosan (DM) and subsequently photopolymerizing DM precursor solution. The hydrogel rapidly polymerized under UV light irradiation (≈2 s) and possessed a strong adhesive strength (273.33 ± 55.07 kPa), facilitating a fast bonding of nerve stump. Especially, its tailored degradation profile over 28 days supported both early gap bridging and subsequent nerve regeneration. Furthermore, deferoxamine (DFO), a pro‐angiogenic drug, is loaded into the hydrogel to reach sustainable release, accelerating axonal growth synergistically. A 3 mm long sciatic nerve defects model in rats is used to investigate the efficacy of DM@DFO hydrogel for repairing peripheral nerve defects. After 60 days, the DM@DFO hydrogel significantly outperformed conventional sutures and fibrin glue, improving motor and sensory recovery by reducing inflammation, inhibiting scar formation, and accelerating vascular regeneration within 14 days post‐repair. This work highlights the DM@DFO hydrogel as a promising tissue adhesive for effective short‐distance peripheral nerve repair.
{"title":"Rapid Forming, Robust Adhesive Fungal‐Sourced Chitosan Hydrogels Loaded with Deferoxamine for Sutureless Short‐Gap Peripheral Nerve Repair","authors":"Qi Dong, Kai Shi, Junjie Ai, Junfeng Yang, Kaidan Yang, Ruina Chen, Yachao Wang, Yingshan Zhou","doi":"10.1002/adhm.202401412","DOIUrl":"https://doi.org/10.1002/adhm.202401412","url":null,"abstract":"Clinically, conventional sutures for repair of short‐distance nerve injuries (< 5 mm) may contribute to uncontrolled inflammation and scar formation, thus negatively impacting nerve regeneration. To repair transected peripheral nerves with short distances, a rapid‐forming, robust adhesive chitosan hydrogel is prepared by synthesizing maleic and dopamine bi‐functionalized fungal‐sourced chitosan (DM) and subsequently photopolymerizing DM precursor solution. The hydrogel rapidly polymerized under UV light irradiation (≈2 s) and possessed a strong adhesive strength (273.33 ± 55.07 kPa), facilitating a fast bonding of nerve stump. Especially, its tailored degradation profile over 28 days supported both early gap bridging and subsequent nerve regeneration. Furthermore, deferoxamine (DFO), a pro‐angiogenic drug, is loaded into the hydrogel to reach sustainable release, accelerating axonal growth synergistically. A 3 mm long sciatic nerve defects model in rats is used to investigate the efficacy of DM@DFO hydrogel for repairing peripheral nerve defects. After 60 days, the DM@DFO hydrogel significantly outperformed conventional sutures and fibrin glue, improving motor and sensory recovery by reducing inflammation, inhibiting scar formation, and accelerating vascular regeneration within 14 days post‐repair. This work highlights the DM@DFO hydrogel as a promising tissue adhesive for effective short‐distance peripheral nerve repair.","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":null,"pages":null},"PeriodicalIF":10.0,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142259676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dye‐based fluorescent organic nanoparticles are a specific class of nanoparticles obtained by nanoprecipitation in water of pure dyes only. While the photophysical and colloidal properties of the nanoparticles strongly depend on the nature of the aggregated dyes, their excellent brightness in the visible and in the near infrared make these nanoparticles a unique and versatile platform for in vivo application. This article examines the promising utilization of these nanoparticles for in vivo optogenetics applications. Their photophysical properties as well as their biocompatibility and their capacity to activate Chrimson opsin in vivo through the fluorescence reabsorption process are demonstrated. Additionally, an illustrative example of employing these nanoparticles in fear reduction in mice through closed‐loop stimulation is presented. Through an optogenetic methodology, the nanoparticles demonstrate an ability to selectively manipulate neurons implicated in the fear response and diminish the latter. Dye‐based fluorescent organic nanoparticles represent a promising and innovative strategy for optogenetic applications, holding substantial potential in the domain of translational neuroscience. This work paves the way for novel therapeutic modalities for neurological and neuropsychiatric disorders.
{"title":"Dye‐Based Fluorescent Organic Nanoparticles, New Promising Tools for Optogenetics","authors":"Jérémy Lesas, Thomas C.M. Bienvenu, Eleonore Kurek, Jean‐Baptiste Verlhac, Zoé Grivet, Maude Têtu, Delphine Girard, Frédéric Lanore, Mireille Blanchard‐Desce, Cyril Herry, Jonathan Daniel, Cyril Dejean","doi":"10.1002/adhm.202402132","DOIUrl":"https://doi.org/10.1002/adhm.202402132","url":null,"abstract":"Dye‐based fluorescent organic nanoparticles are a specific class of nanoparticles obtained by nanoprecipitation in water of pure dyes only. While the photophysical and colloidal properties of the nanoparticles strongly depend on the nature of the aggregated dyes, their excellent brightness in the visible and in the near infrared make these nanoparticles a unique and versatile platform for in vivo application. This article examines the promising utilization of these nanoparticles for in vivo optogenetics applications. Their photophysical properties as well as their biocompatibility and their capacity to activate Chrimson opsin in vivo through the fluorescence reabsorption process are demonstrated. Additionally, an illustrative example of employing these nanoparticles in fear reduction in mice through closed‐loop stimulation is presented. Through an optogenetic methodology, the nanoparticles demonstrate an ability to selectively manipulate neurons implicated in the fear response and diminish the latter. Dye‐based fluorescent organic nanoparticles represent a promising and innovative strategy for optogenetic applications, holding substantial potential in the domain of translational neuroscience. This work paves the way for novel therapeutic modalities for neurological and neuropsychiatric disorders.","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":null,"pages":null},"PeriodicalIF":10.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142222705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yiyong Wu, Lulu Wang, Mengying Yan, Xufang Wang, Xin Liao, Cheng Zhong, Dingning Ke, Yi Lu
Neural Electrode Interface
In article 2400836, Dingning Ke, Yi Lu, and co-workers develop a highly robust electrode-neural interface using an in situ electrochemical deposition strategy combined with negatively charged group doping. This neural electrode boasts remarkable electrochemical and mechanical stability, as well as excellent biocompatibility, enabling long-term tracking and electrophysiological recording of neuronal activity in free-behaving animals.